KBC Group
ETON icon

KBC Group’s Eton Pharmaceutcials ETON Stock Holding History

KBC Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66K Buy
+1,285
New +$65.2K ﹤0.01% 1622

Other funds holding ETON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

KBC Group's ETON Position: Q3 2026 in Review

KBC Group opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 1,285 shares worth $66K. The stake represents ﹤0.01% of the portfolio and ranks #1622 among its holdings.

127 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • KBC Group held 1,285 shares of Eton Pharmaceutcials worth $66K as of Q3 2026.
  • Eton Pharmaceutcials was a new KBC Group position in Q3 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1622 holding.
  • 127 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.